02:20 PM EST, 11/13/2025 (MT Newswires) -- Clearmind Medicine ( CMND ) received final approval from Hadassah Medical Center in Jerusalem for its ongoing Phase 1/2a trial of CMND-100, an oral drug candidate based on the company's novel psychoactive compound targeting alcohol use disorder. The first cohort treatment has been successfully completed, Clearmind said Thursday in a statement. The multicenter...

02:16 PM EST, 11/13/2025 (MT Newswires) -- IGC Pharma ( IGC ) said Thursday the US Patent and Trademark Office has granted the company a patent titled Methods and Composition for Treating CNS Disorders. The patent covers the formulation used in IGC-AD1, its lead drug candidate being evaluated in the phase 2 trial for agitation in Alzheimer's disease, the clinical-stage...

(Reuters) -Novo Nordisk and Eli Lilly ( LLY ) do not have a weight-loss drug partnership with telehealth website Mangoceuticals Inc ( MGRX ), spokespeople for both companies said, rejecting a press release issued by the company on Thursday that described arrangements with the two leading drugmakers. Spokespeople for both companies said in emails to Reuters that they had no...

02:20 PM EST, 11/13/2025 (MT Newswires) -- ENDRA Life Sciences ( NDRA ) said Thursday that it has commenced the staking its holdings of HYPE, the native token of the Hyperliquid ecosystem. The staking initiative is expected to maximize the utility and return of the company's HYPE while, contributing towards the security and decentralization of the underlying blockchain network, ENDRA...